CN Patent
CN103561727A — 每日给药1次的拉科酰胺制剂
Assigned to Ucb Pharma Inc · Expires 2014-02-05 · 12y expired
What this patent protects
拉科酰胺控释制剂适合每日服用1次。
USPTO Abstract
拉科酰胺控释制剂适合每日服用1次。
Drugs covered by this patent
- Vimpat (lacosamide) · UCB
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.